drugset / Trial / NCT00420628

Pediatric Zylet Safety and Efficacy Study

NCT00420628

Phase 4 Completed 108 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)

Timeline

Start
2006-11
Primary completion
2009-01
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Loteprednol Etabonate Other / unclassified 0.5 % Topical
Subject Tobramycin Small molecule 0.3 % Topical

Indications